Sponsor:
Massachusetts General Hospital
Code:
NCT03032835
Conditions
Calciphylaxis
Calcific Uremic Arteriolopathy
End Stage Renal Disease
Chronic Kidney Diseases
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Calciphylaxis
Calcific Uremic Arteriolopathy
End Stage Renal Disease
Chronic Kidney Diseases
Study ID
NCT03032835
Start date
Jan, 2017
Status verified date
Nov, 2024
Completion date
Dec, 2030
Anticipated
Primary completion date
Dec, 2030
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
300 participants
Anticipated
Arms
Study participants
Primary outcome measure
Central contacts
Locations
Massachusetts General Hospital
Recruiting
Boston, Massachusetts, United States, 02114
Contacts
Sponsor
Massachusetts General Hospital
Last update posted
Nov 19, 2024
Last verified
Nov, 2024
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2024-11-19.